Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Rowe

Showing results (401-410 of 1,408) with videos related to

Pageof 141
Sort By:
Blood Reviews|September 1, 1996
Treatment of the neutropenia of Felty syndromeE J Rashba, J M Rowe, C H Packman
Open Life Sciences|July 21, 2025
Advancements in curcuminoid formulations: An update on bioavailability enhancement strategies curcuminoid bioavailability and formulationsAlexander Darmonkow, Zoë E M Rowe, Scott V Harding
Clinical Nuclear Medicine|April 1, 1985
Focal bone marrow activity. A false-positive on a sulfur colloid bleeding studyD M Rowe, D S Schauwecker, H M Park
Biochemistry|October 21, 1986
Purification and characterization of a human pituitary growth factorJ M Rowe, S F Henry, H G Friesen
Methods in Enzymology|January 1, 1987
Calmodulin as an activator and a substrate of methyltransferase enzymesF L Siegel, L S Wright, P M Rowe
Blood|May 5, 2005
Drug therapy for acute myeloid leukemiaMartin S Tallman, D Gary Gilliland, Jacob M Rowe
Bone Marrow Transplantation|March 2, 1997
Prevention and treatment of acute graft-versus-host disease: the old and the new. A report from the Eastern Cooperative Oncology Group (ECOG)H M Lazarus, G B Vogelsang, J M Rowe
Psychological Research|May 28, 2025
Even with exposure to errors, motor imagery cannot update internal modelsJuliet M Rowe, Brooke C Cramer, Shaun G Boe
The Journal of Allergy and Clinical Immunology|April 1, 1990
Rose hips: a new occupational allergenA Kwaselow, M Rowe, D Sears-Ewald, et al.
Transplant Immunology|December 1, 2012
A subset of CD8+ T cells acquiring selective suppressive properties may play a role in GvHD managementIrit Avivi, Dina Stroopinsky, Jacob M Rowe, et al.
Pageof 141

Showing results (401-410 of 1,408) with videos related to

Sort By:
Pageof 141
Blood Reviews|September 1, 1996
Treatment of the neutropenia of Felty syndromeE J Rashba, J M Rowe, C H Packman
Open Life Sciences|July 21, 2025
Advancements in curcuminoid formulations: An update on bioavailability enhancement strategies curcuminoid bioavailability and formulationsAlexander Darmonkow, Zoë E M Rowe, Scott V Harding
Clinical Nuclear Medicine|April 1, 1985
Focal bone marrow activity. A false-positive on a sulfur colloid bleeding studyD M Rowe, D S Schauwecker, H M Park
Biochemistry|October 21, 1986
Purification and characterization of a human pituitary growth factorJ M Rowe, S F Henry, H G Friesen
Methods in Enzymology|January 1, 1987
Calmodulin as an activator and a substrate of methyltransferase enzymesF L Siegel, L S Wright, P M Rowe
Blood|May 5, 2005
Drug therapy for acute myeloid leukemiaMartin S Tallman, D Gary Gilliland, Jacob M Rowe
Bone Marrow Transplantation|March 2, 1997
Prevention and treatment of acute graft-versus-host disease: the old and the new. A report from the Eastern Cooperative Oncology Group (ECOG)H M Lazarus, G B Vogelsang, J M Rowe
Psychological Research|May 28, 2025
Even with exposure to errors, motor imagery cannot update internal modelsJuliet M Rowe, Brooke C Cramer, Shaun G Boe
The Journal of Allergy and Clinical Immunology|April 1, 1990
Rose hips: a new occupational allergenA Kwaselow, M Rowe, D Sears-Ewald, et al.
Transplant Immunology|December 1, 2012
A subset of CD8+ T cells acquiring selective suppressive properties may play a role in GvHD managementIrit Avivi, Dina Stroopinsky, Jacob M Rowe, et al.
Pageof 141